Mathew Aby J., EVP and Chief Scientific Officer of BioLife Solutions Inc. ($BLFS), made 12 open market sales of company shares over the past year, totaling $385,720. His most recent BLFS insider sale occurred on March 3, 2026. These transactions rank him 7,026th among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions. Mathew Aby J. reported no open market purchases of $BLFS stock in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | F | Common Stock | 2255 | $19.12 | 390,682.0000 | 48,723,535 | 0.57% | 0.00% |
| March 3, 2026 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 529 | $20.74 | 392,937.0000 | 48,723,535 | 0.13% | 0.00% |
| Feb. 24, 2026 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | F | Common Stock | 15585 | $22.65 | 393,466.0000 | 48,723,535 | 3.81% | 0.03% |
| Feb. 24, 2026 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | A | Common Stock | 20096 | $0.00 | 369,446.0000 | 48,723,535 | 5.75% | 0.04% |
| Feb. 24, 2026 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | A | Common Stock | 39605 | $0.00 | 409,051.0000 | 48,723,535 | 10.72% | 0.08% |
| Jan. 6, 2026 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 405 | $25.59 | 349,350.0000 | 48,723,535 | 0.12% | 0.00% |
| Dec. 9, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 631 | $25.13 | 349,755.0000 | 48,723,535 | 0.18% | 0.00% |
| Nov. 25, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 526 | $26.74 | 350,386.0000 | 48,723,535 | 0.15% | 0.00% |
| Oct. 9, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 509 | $27.36 | 350,912.0000 | 48,723,535 | 0.14% | 0.00% |
| Sept. 11, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 630 | $26.83 | 351,421.0000 | 46,067,073 | 0.18% | 0.00% |
| Aug. 26, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 531 | $25.44 | 352,051.0000 | 46,067,073 | 0.15% | 0.00% |
| July 7, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 536 | $22.27 | 352,582.0000 | 46,067,073 | 0.15% | 0.00% |
| June 10, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 637 | $23.70 | 353,118.0000 | 46,067,073 | 0.18% | 0.00% |
| May 29, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | A | Common Stock | 45269 | $0.00 | 353,755.0000 | 46,067,073 | 14.67% | 0.10% |
| May 28, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 521 | $22.46 | 308,486.0000 | 46,067,073 | 0.17% | 0.00% |
| April 9, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 569 | $20.11 | 309,007.0000 | 46,067,073 | 0.18% | 0.00% |
| April 1, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 10589 | $22.66 | 309,576.0000 | 46,067,073 | 3.31% | 0.02% |
| March 18, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | A | Common Stock | 36645 | $0.00 | 320,165.0000 | 46,067,073 | 12.93% | 0.08% |
| March 18, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | A | Common Stock | 22919 | $0.00 | 283,520.0000 | 46,067,073 | 8.79% | 0.05% |
| March 11, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 1597 | $25.00 | 260,601.0000 | 46,067,073 | 0.61% | 0.00% |
| March 3, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 425 | $25.46 | 262,198.0000 | 46,067,073 | 0.16% | 0.00% |
| Feb. 12, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 92 | $26.54 | 262,623.0000 | 46,067,073 | 0.04% | 0.00% |
| Jan. 6, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 404 | $27.02 | 262,715.0000 | 46,067,073 | 0.15% | 0.00% |
| Dec. 16, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 7604 | $27.33 | 276,315.0000 | 46,175,345 | 2.68% | 0.02% |
| Dec. 17, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 13196 | $27.16 | 263,119.0000 | 46,175,345 | 4.78% | 0.03% |
| Nov. 26, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 523 | $27.20 | 283,919.0000 | 46,175,345 | 0.18% | 0.00% |
| Nov. 15, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Employee Stock Option | 10000 | $0.00 | 0.0000 | 46,175,345 | 100.00% | 0.02% |
| Nov. 18, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 17604 | $20.05 | 284,442.0000 | 46,175,345 | 5.83% | 0.04% |
| Nov. 15, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 15000 | $21.17 | 302,046.0000 | 46,175,345 | 4.73% | 0.03% |
| Nov. 15, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 10000 | $21.16 | 317,046.0000 | 46,175,345 | 3.06% | 0.02% |
| Nov. 15, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Common Stock | 10000 | $2.06 | 327,046.0000 | 46,175,345 | 3.15% | 0.02% |
| Nov. 12, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 123 | $26.34 | 317,046.0000 | 46,175,345 | 0.04% | 0.00% |
| Oct. 30, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 547 | $23.15 | 317,169.0000 | 46,175,345 | 0.17% | 0.00% |
| Oct. 15, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 10000 | $23.28 | 317,716.0000 | 46,175,345 | 3.05% | 0.02% |
| Oct. 16, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Employee Stock Option | 10000 | $0.00 | 10,000.0000 | 46,175,345 | 50.00% | 0.02% |
| Oct. 16, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Common Stock | 10000 | $2.06 | 327,716.0000 | 46,175,345 | 3.15% | 0.02% |
| Oct. 16, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 10000 | $23.17 | 317,716.0000 | 46,175,345 | 3.05% | 0.02% |
| Oct. 15, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Employee Stock Option | 10000 | $0.00 | 20,000.0000 | 46,175,345 | 33.33% | 0.02% |
| Oct. 15, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Common Stock | 10000 | $2.06 | 327,716.0000 | 46,175,345 | 3.15% | 0.02% |
| Sept. 19, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 10000 | $25.47 | 317,716.0000 | 43,719,185 | 3.05% | 0.02% |
| Sept. 18, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Employee Stock Option | 10000 | $0.00 | 40,000.0000 | 43,719,185 | 20.00% | 0.02% |
| Sept. 19, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Employee Stock Option | 10000 | $0.00 | 30,000.0000 | 43,719,185 | 25.00% | 0.02% |
| Sept. 18, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Common Stock | 10000 | $2.06 | 327,716.0000 | 43,719,185 | 3.15% | 0.02% |
| Sept. 18, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 10000 | $23.90 | 317,716.0000 | 43,719,185 | 3.05% | 0.02% |
| Sept. 19, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | M | Common Stock | 10000 | $2.06 | 327,716.0000 | 43,719,185 | 3.15% | 0.02% |
| July 11, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 313 | $20.54 | 318,170.0000 | 43,719,185 | 0.10% | 0.00% |
| Sept. 16, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 343 | $25.12 | 317,716.0000 | 43,719,185 | 0.11% | 0.00% |
| Aug. 21, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 111 | $25.61 | 318,059.0000 | 43,719,185 | 0.03% | 0.00% |
| May 29, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 517 | $21.78 | 318,483.0000 | 43,719,185 | 0.16% | 0.00% |
| May 17, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 98 | $22.18 | 319,000.0000 | 43,719,185 | 0.03% | 0.00% |
| April 18, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 584 | $15.31 | 319,098.0000 | 43,719,185 | 0.18% | 0.00% |
| March 27, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 454 | $17.99 | 319,682.0000 | 43,719,185 | 0.14% | 0.00% |
| March 12, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 6521 | $16.60 | 320,136.0000 | 43,719,185 | 2.00% | 0.01% |
| March 8, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | A | Common Stock | 25470 | $0.00 | 300,684.0000 | 43,719,185 | 9.25% | 0.06% |
| March 8, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | A | Common Stock | 26286 | $0.00 | 326,970.0000 | 43,719,185 | 8.74% | 0.06% |
| March 11, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 313 | $17.42 | 326,657.0000 | 43,719,185 | 0.10% | 0.00% |
| Feb. 21, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 101 | $17.35 | 275,214.0000 | 43,719,185 | 0.04% | 0.00% |
| Jan. 19, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 1450 | $16.76 | 275,315.0000 | 43,719,185 | 0.52% | 0.00% |
| Jan. 2, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | S | Common Stock | 697 | $16.75 | 276,765.0000 | 43,719,185 | 0.25% | 0.00% |